Pioneering Equity crowdfunding campaign

You are here

Iproteos has just released an innovative campaign based on Equity crowdfunding. It is the first time that this strategy is used in a Spanish biotechnological project. The company aims to generate a pioneering manner of raising funds for early stage biotech companies, as it is carried out in United Kingdom and France. The objective of the campaign is to raise 100,000€ to complete the non-regulatory preclinical trials of a project devoted to a treatment for Schizophrenia. This will allow Iproteos to attract further investment to move on to clinical trials in patients. Further details about the project and the crowdfunding campaign can be found at: